Aryo Nikopour has been named vice president of scientific and technical services, and Greg McParland has been named chief operating officer at Irvine Pharmaceutical Services. These changes were made to accommodate the company’s growth, as well as the anticipated launch of its new subsidiary, Avrio Biopharmaceuticals, in January 2009.     Mr. Nikopour has spent five years at Irvine and has more than 20 years of experience in the pharmaceutical industry. His previous positions — at organizatio...